|3 Months Ended|
Mar. 31, 2020
|Income Tax Disclosure [Abstract]|
|INCOME TAX||INCOME TAXOn March 27, 2020, the President signed into law the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), an economic stimulus package in response to the COVID-19 global pandemic. The CARES Act contains several corporate income tax provisions, including making remaining AMT credits immediately refundable; providing a 5-year carryback of net operating losses ("NOL") generated in tax years 2018, 2019, and 2020, and removing the 80% taxable income limitation on utilization of those NOL if carried back to prior tax years or utilized in tax years beginning before 2021, among others. The Company intends to avail itself of these new provisions and are reflected in the results as of March 31, 2020.The Company had a tax expense of $41,000 for the three months ended March 31, 2020 and is comprised of federal and state tax benefits on current period losses, along with a net federal tax expense for the impact of the CARES Act, resulting in an effective tax rate on a YTD basis of approximately -1.0%. The Company had a tax benefit of $2.3 million for the three months ended March 31, 2019, comprising of a federal tax benefit and a state tax benefit of $1.7 million and $0.6 million, respectively. The computed effective tax rate for the three months ended March 31, 2019, is approximately 28.00%.|
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef